5 Best Stocks Under $15 According to Billionaire Michael Price

In this article, we will take a look at the 5 best stocks under $15 according to Billionaire Michael Price. If you wish to see our detailed analysis of Price’s history, investment philosophy, and hedge fund performance, go directly to 10 Best Stocks Under $15 According to Billionaire Michael Price.

5. Siga Technologies, Inc. (NASDAQ:SIGA)

Price’s Stake Value: $7.5 million

Percentage of Michael Price’s 13F Portfolio: 0.83%

Number of Hedge Fund Holders: 13

Stock Price as of September 29: $7.31

Siga Technologies, Inc. (NASDAQ:SIGA) is a New York-based pharmaceutical company that markets anti-viral treatments for lethal pathogens. Ranked fifth on the list of the 10 best stocks under $15 according to Michael Price, Siga Technologies, Inc. (NASDAQ:SIGA) has a market capitalization of $548.81 million.

Michael Price’s MFP Investors currently holds over 1.2 million shares of Siga Technologies, Inc. (NASDAQ:SIGA), worth more than $7.5 million and accounting for 0.83% of the fund’s portfolio. At the end of the second quarter of 2021, 13 hedge funds in the database of Insider Monkey held stakes worth more than $28.3 million in Siga Technologies, Inc. (NASDAQ:SIGA). The number of hedge funds that held stakes within the company remained the same for the first and second quarters of 2021.

At the end of the second quarter of 2021, Siga Technologies, Inc. (NASDAQ:SIGA) reported revenues amounting to over $8.65 million.

Steel City Capital, an investment management firm, mentioned SIGA Technologies, Inc. (NASDAQ:SIGA) in its Q2 2021 investor letter. Here is what the fund said:

“As “I go to print,” there’s a small possibility that SIGA Technologies (SIGA) is on the cusp of “meme stock” status, although I’m not holding my breath, and that’s certainly not the reason we own shares. SIGA is a commercial stage pharmaceutical company whose sole product, TPOXX, is an antiviral drug approved by the FDA for the treatment of smallpox. The company has an option-based contract to replenish the U.S. Government’s existing stockpile of the drug over the next several years. The remaining value of the contract if fully exercised – which I believe it will be – will generate more than $400 million in revenue for SIGA. The company is also pursuing a variety of growth initiatives both domestically and abroad. At recent prices, shares are trading at a mid-single digit P/E multiple.

So, what has made the company a viable “meme stock” candidate? As of this morning, more than 200 people in 27 states are being monitored for possible exposure to monkeypox after they had contract with an individual who contracted the disease in Nigeria before traveling to the United States this month. While SIGA’s drug is approved only for smallpox, the company is pursuing approval in Europe for indications that include smallpox, cowpox, and monkeypox. I believe the “Twittersphere” is starting to take notice of the connection. If nothing else, the monkeypox scare should reinforce to the U.S. Government and other governments around the world that deadly viral outbreaks are highly unpredictable yet unfortunately very possible. While we’re still learning lessons from COVID-19, I expect health and government officials around the world to make the calculation that it’s better to be prepared for such outbreaks before they occur. That should bode well for SIGA’s prospects.”

4. BlackBerry Limited (NYSE:BB)

Price’s Stake Value: $10.3 million

Percentage of Michael Price’s 13F Portfolio: 1.14%

Number of Hedge Fund Holders: 20

Stock Price as of September 29: $9.60

BlackBerry Limited (NYSE:BB) is a cybersecurity company based in Waterloo, Canada. Ranked fourth on the list of the 10 best stocks under $15 according to Michael Price, the company provides security software that make use of artificial intelligence and machine learning against cyberthreats.

The company reported revenues of $266 million in its earnings report for Q2 2021, which beat estimates by $26.26 million. The EPS was reported to be $0.11, surpassing estimates for the quarter by $0.09.

According to the recent 13F Filings, MFP Investors holds 850,000 stakes of BlackBerry Limited (NYSE:BB), amounting to over $10.3 million in worth, representing 1.14% of the investment fund’s portfolio. At the end of the second quarter of 2021, 20 hedge funds in the database of Insider Monkey held stakes worth more than $732 million in BlackBerry Limited (NYSE:BB). This is compared to 24 hedge funds in the previous quarter that held stakes amounting to approximately $499.7 million.

On September 23, TD Securities analyst Daniel Chan raised the his price target on BlackBerry Limited (NYSE:BB) to $9 from $8.50 and kept a Reduce rating on the shares after the company issued its Q2 earnings report.

Out of the hedge funds being tracked by Insider Monkey, New York-based investment fund Kahn Brothers is a leading shareholder of BlackBerry Limited (NYSE:BB), with over 1.76 million shares worth $21.54 billion.

3. Crimson Wine Group, Ltd (OTCMKTS:CWGL)

Price’s Stake Value: $10.4 million

Percentage of Michael Price’s 13F Portfolio: 1.15%

Number of Hedge Fund Holders: 1

Stock Price as of September 29: $8.59

Crimson Wine Group, Ltd (OTCMKTS:CWGL) is a California-based beverage company that engages in the production and sales of premium wines. Ranked third on the list of the 10 best stocks under $15 according to Michael Price, Crimson Wine Group, Ltd (OTCMKTS:CWGL) has a market capitalization of $193.48 million.

For the second quarter of 2021, the company reported GAAP EPS of $0.25, alongside revenues generated amounting to over $9.25 million, an increase of 6.02% on a year-over-year basis.

Michael Price’s MFP Investors presently holds more than 1.14 million shares of Crimson Wine Group, Ltd (OTCMKTS:CWGL), amounting to over $10.4 million in worth, accounting for 1.15% of the fund’s total portfolio value. At the end of the second quarter of 2021, just 1 hedge fund in the database of Insider Monkey held stakes worth more than $10.4 million in Crimson Wine Group, Ltd (OTCMKTS:CWGL).

2. BCB Bancorp, Inc. (NASDAQ:BCBP)

Price’s Stake Value: $13.7 million

Percentage of Michael Price’s 13F Portfolio: 1.51%

Number of Hedge Fund Holders: 7

Stock Price as of September 29: $14.88

BCB Bancorp, Inc. (NASDAQ:BCBP) is a New Jersey-based bank holding company that provides financial solutions, as well as retail and commercial banking services. The company is ranked second on our list of the 10 best stocks under $15 according to Michael Price.

At present, Michael Price’s hedge fund holds over 1.02 million shares of BCB Bancorp, Inc. (NASDAQ:BCBP), worth more than $13.7 million and representing 1.51% of the fund’s total investment portfolio. At the end of the second quarter of 2021, 7 hedge funds in the database of Insider Monkey held stakes worth more than $28 million in BCB Bancorp, Inc. (NASDAQ:BCBP), up from 3 hedge funds in the preceding quarter that held stakes amounting to approximately $21.3 million.

On July 19, BCB Bancorp, Inc. (NASDAQ:BCBP) issued its quarterly earnings report for the second quarter of 2021, with reported earnings per share at $0.46, crossing market predictions by $0.05. Additionally, the company reported quarterly revenues of $26.88 million, an increase of 40.76% on a year-over-year basis, beating forecast estimates by $1.39 million.

1. S&W Seed Company (NASDAQ:SANW)

Price’s Stake Value: $58.4 million

Percentage of Michael Price’s 13F Portfolio: 6.45%

Number of Hedge Fund Holders: 4

Stock Price as of September 29: $2.60

S&W Seed Company (NASDAQ:SANW) is a multi-crop agricultural company that provides a wide range of forage, grain and other specialty crop products. Based in Colorado, S&W Seed Company (NASDAQ:SANW) is ranked first on the list of the 10 best stocks under $15 according to Michael Price.

According to the recent 13F Filings, Michael Price’s MFP Investors holds over 16 million shares of S&W Seed Company (NASDAQ:SANW), amounting to over $58.4 million in worth, accounting for 6.45% of the fund’s total portfolio value. At the end of the second quarter of 2021, 4 hedge funds in the database of Insider Monkey held stakes worth more than $75.7 million in S&W Seed Company (NASDAQ:SANW), down from 7 hedge funds in the previous quarter that held stakes amounting to over $78 million.

At the end of the second quarter of 2021, S&W Seed Company (NASDAQ:SANW) reported EPS of -$0.23, missing estimates by $0.06. The company also reported revenues generated amounting to over $15.05 million, beating market predictions by $0.38 million.

On September 29, B. Riley analyst Sarkis Sherbetchyan lowered the his price target on S&W Seed Company (NASDAQ:SANW) to $4.25 from $5 and kept a Buy rating on the shares.

Long Cast Advisers, in its Q1 2021 investor letter, mentioned S&W Seed Company (NASDAQ:SANW). Here is what the fund said:

“You likely notice we’ve been purchasing S & W Seed (SANW), a producer and manufacturer of agricultural seeds. At current price of $3.90 and with 34M diluted shares and $50M in debt, SANW has an enterprise value of ~$180M. Against trailing 12-month sales, this infers a 2x EV / sales multiple which is in the mid point of the 1x-3x range typically seen in the industry space.

My interest in the company was piqued b/c I was looking for something that would work as a potential commodity hedge against inflation, and agriculture tends to do that. Digging in, I saw two broad attributes that make this company compelling…” (Click here to see the full text)

You can also take a peek at 10 Best Stocks to Buy According to Billionaire Daniel Sundheim and Best Stocks to Buy According to Billionaire Barry Rosenstein’s Jana Partners.